MARQUIS JEFFERSON: Open Payments
NPI 1376281972 · DELRAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 93 payments from 17 companies in 2025. Trend: 2023 $1,431 · 2024 $1,457 · 2025 $1,354
Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $285 |
| Novartis Pharmaceuticals Corporation | 13 | $181 |
| UCB, Inc. | 12 | $144 |
| Janssen Biotech, Inc. | 6 | $106 |
| Lilly USA, LLC | 6 | $90 |
| LEO Pharma Inc. | 5 | $77 |
| Botanix SB Inc | 4 | $73 |
| Galderma Laboratories, L.P. | 4 | $63 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $61 |
| Incyte Corporation | 4 | $61 |
Products named: SKYRIZI, Bimzelx, COSENTYX, RINVOQ, TREMFYA, TALTZ, SOFDRA, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
